PETALING JAYA: The healthcare sector is expected to see a stronger performance this year, with hospitals benefiting from the rebound in the number of local and foreign patient visits.
Pharmaceutical companies, on the other hand, are expected to benefit from robust drug procurement activities on both the public and private sector fronts amid softer demand in the over-the-counter (OTC) format.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
